An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade

Shuguang Zuo(Nanjing University), Jiwu Wei(Nanjing Medical University), Junhua Wu(South China Agricultural University), Tiancheng Xu(Nanjing University of Chinese Medicine), Bohao He(China Pharmaceutical University), Jie Dong(Nanjing Medical University), Min Wei(Nanjing University), Shibing Wang(Zhejiang Provincial People's Hospital), Lingkai Kong(Nanjing University), Shiqun Wang(Zhejiang Cancer Hospital)
Journal for ImmunoTherapy of Cancer
December 1, 2021
Cited by 75


Related Papers